ARTICLE
|
doi:10.20944/preprints202205.0142.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
glioblastoma; immunotherapy; radiotherapy; brain cancers; radioimmunotherapy; immune checkpoint inhibitors; temozolomide; durvalumab; immunoradiotherapy.
Online: 10 May 2022 (13:22:16 CEST)
ARTICLE
|
doi:10.20944/preprints202312.0497.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
pembrolizumab; immunotherapy; temozolomide; durvalumab; brain tumor; cell migration; metastasis; glioblastoma; PD-1; PD-L1
Online: 7 December 2023 (16:57:26 CET)
ARTICLE
|
doi:10.20944/preprints201808.0307.v3
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
Immune Checkpoint Inhibitors; anti-PD-1/PDL-1; anti-CTLA-4; gender; sex; Nivolumab; Pembrolizumab; Atezolizumab; Ipilimumab; Durvalumab
Online: 15 November 2018 (07:02:24 CET)